Listed

Mettler Toledo International Inc/: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 8, 2019 and accepted by EDGAR at Nov 8, 2019, 11:08 ET.

Share

Management's discussion and analysis

As filed, 33,322 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.

General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results to be expected for the full year ending December 31, 2019.

Changes in local currency exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.

Results of Operations – Consolidated

The following tables set forth certain items from our interim consolidated statements of operations for the three and nine month periods ended September 30, 2019 and 2018 (amounts in thousands).

Three months ended September 30, 2019 (unaudited)% 2018 (unaudited)% Nine months ended September 30, 2019 (unaudited)% 2018 (unaudited)%
Net sales $753,866 100.0 $734,846 100.0 $2,164,684 100.0 $2,117,663 100.0
Cost of sales 318,810 42.3 315,592 42.9 921,771 42.6 910,851 43.0
Gross profit 435,056 57.7 419,254 57.1 1,242,913 57.4 1,206,812 57.0
Research and development 36,015 4.8 34,838 4.7 108,650 5.0 104,866 5.0
Selling, general and administrative 202,826 26.9 202,451 27.6 612,466 28.3 611,149 28.9
Amortization 12,329 1.6 11,856 1.6 36,877 1.7 35,561 1.7
Interest expense 9,800 1.3 9,003 1.2 27,776 1.3 25,671 1.2
Restructuring charges 6,732 0.9 2,222 0.3 11,146 0.5 13,956 0.6
Other charges (income), net (2,005) (0.3) (1,479) (0.1) (4,253) (0.2) (5,795) (0.3)
Earnings before taxes 169,359 22.5 160,363 21.8 450,251 20.8 421,404 19.9
Provision for taxes 39,964 5.3 33,710 4.6 81,891 3.8 89,979 4.2
Net earnings $129,395 17.2 $126,653 17.2 $368,360 17.0 $331,425 15.7

Net sales

Net sales were $753.9 million and $734.8 million for the three months ended September 30, 2019, and 2018, and $2.2 billion and $2.1 billion for the nine months ended September 30, 2019 and 2018, respectively. This represents an increase of 3% and 2% in U.S. dollars for the three and nine months ended September 30, 2019. Excluding the effect of currency exchange rates fluctuations, or in local currencies, net sales increased 4% and 5% for the three and nine months ended September 30, 2019. Net sales were reduced by 2% in both the three and nine month periods ended September 30, 2019 related to a significant decline in food retailing as further explained below. Global market conditions were generally favorable during the first nine months of 2019 and we continue to benefit from the execution of our global sales and marketing programs, our innovative product portfolio, and investments in our field resources. However, we remain cautious due to greater uncertainty in the global macroeconomic environment. Economic conditions can also change quickly, particularly in emerging markets. We will also face more difficult prior year comparisons in the fourth quarter of 2019 related to our strong previous year growth.

Net sales by geographic destination for the three and nine months ended September 30, 2019 in U.S. dollars increased in the Americas 6% and 5%, in Asia/Rest of World 2% and 3% and decreased in Europe 2% for both periods, respectively. Our net sales by geographic destination for the three and nine months ended September 30, 2019 in local currencies increased in the Americas 7% and 5%, in Europe 2% and 3% and in Asia/Rest of World 4% and 7%, respectively. Net sales in the Americas was reduced by 2% and 3% and in Europe by 2% and 1% for the three and nine months ended September 30, 2019 related to a significant decline in food retailing sales primarily due to unfavorable market conditions and the timing of project activity. A discussion of sales by operating segment is included below.

As described in Note 18 to our consolidated financial statements for the year ended December 31, 2018, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products increased 2% in U.S. dollars and 4% in local currencies for the three months ended September 30, 2019 and increased 2% in U.S. dollars and 5% in local currencies for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Service revenue (including spare parts) increased by 5% in U.S. dollars and 7% in local currencies for the three months ended September 30, 2019 and increased 4% in U.S. dollars and 7% in local currencies for the nine months ended September 30, 2019, compared to the corresponding periods in 2018.

Net sales of our laboratory products and services, which represented approximately 52% of our total net sales increased 5% in U.S. dollars and 7% in local currencies for both the three and nine months ended September 30, 2019. The local currency increase in net sales of our laboratory-related products for the three and nine months ended September 30, 2019 includes solid growth in most product categories, especially analytical instruments, pipettes and process analytics.

Net sales of our industrial products and services, which represented approximately 41% of our total net sales decreased 3% in U.S. dollars and increased 5% in local currencies for the three months ended September 30, 2019, and increased 2% in U.S. dollars and 5% in local currencies for the nine months ended September 30, 2019. The local currency increase in net sales of our industrial-related products for the three and nine months ended September 30, 2019 included strong growth in core industrial products.

Net sales in our food retailing products and services, which represented approximately 7% of our total net sales decreased 17% in U.S. dollars and 15% in local currencies for the three months ended September 30, 2019, and decreased 13% in U.S. dollars and 10% in local currencies for the nine months ended September 30, 2019. The decline in food retailing is primarily due to unfavorable market conditions and the timing of project activity.

Gross profit

Gross profit as a percentage of net sales was 57.7% and 57.1% for the three months ended September 30, 2019 and 2018, and 57.4% and 57.0% for the nine months ended September 30, 2019 and 2018, respectively.

Gross profit as a percentage of net sales for products was 60.2% and 59.6% for the three months ended September 30, 2019 and 2018, respectively, and 60.0% and 60.2% for the nine months ended September 30, 2019 and 2018, respectively.

Gross profit as a percentage of net sales for services (including spare parts) was 48.9% and 47.8% for the three months ended September 30, 2019 and 2018, respectively, and 48.5% and 45.8% for the nine months ended September 30, 2019 and 2018, respectively.

The increase in gross profit as a percentage of net sales for the three and nine months ended September 30, 2019 reflects favorable price realization, productivity and business mix, partially offset by tariff costs and initial costs associated with new product introductions.

In 2018, the U.S. government enacted tariffs on certain products imported from China. The tariffs became effective at various points during 2018. We estimate the associated annualized cost increase is approximately $25 million (assuming a 25% tariff rate). We continue to implement various actions to mitigate the effects of these tariffs.

Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales was 4.8% and 4.7% for the three months ended September 30, 2019 and 2018, and was 5.0% for both the nine months ended September 30, 2019 and 2018, respectively. Research and development expenses increased 3% in U.S. dollars and 4% in local currencies for the three months ended September 30, 2019, and increased 5% in U.S. dollars and 7% in local currencies for the nine months ended September 30, 2019, respectively, compared to the corresponding periods in 2018 relating to increased project activity.

Selling, general and administrative expenses as a percentage of net sales were 26.9% and 27.6% for the three months ended September 30, 2019 and 2018, and was 28.3% and 28.9% for the nine months ended September 30, 2019 and 2018, respectively. Selling, general and administrative expenses was flat in U.S. dollars and increased 2% in local currencies for the three months ended September 30, 2019, and were flat in U.S. dollars and increased 3% in local currencies for the nine months ended September 30, 2019. The local currency increase includes investments in our field sales organization and growth initiatives, offset in part by benefits from our cost savings initiatives.

Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $12.3 million and $11.9 million for the three months ended September 30, 2019 and 2018, respectively, and $36.9 million and $35.6 million for the nine months ended September 30, 2019 and 2018, respectively.

Interest expense was $9.8 million and $9.0 million for the three months ended September 30, 2019 and 2018, respectively, and $27.8 million and $25.7 million for the nine months ended September 30, 2019 and 2018, respectively.

Other charges (income), net includes non-service pension costs (benefits), (gains) losses from foreign currency transactions and related hedging activities, interest income and other items. Nonservice pension benefits was $1.2 million and $1.6 million for the three months ended September 30, 2019 and 2018, respectively, and $3.5 million and $4.7 million and for the nine months ended September 30, 2019 and 2018, respectively.

Our reported tax rate was 23.6% and 21.0% during the three months ended September 30, 2019 and 2018, respectively, and was 18.2% and 21.4% during the nine months ended September 30, 2019 and 2018, respectively. The provision for taxes is based upon using our projected annual effective tax rate of 20% and 22% before non-recurring discrete tax items for the three and nine months ended September 30, 2019 and 2018, respectively. The difference between our projected annual effective tax rate and the reported tax rate is primarily related to the timing of excess tax benefits associated with stock option exercises.

In May 2019, a public referendum was held in Switzerland that approved Swiss federal tax reform proposals previously approved by Swiss Parliament. The changes in Swiss federal tax had an immaterial effect on our financial statements. Additional changes in Swiss cantonal law were enacted in October 2019. We expect to recognize a discrete non-cash deferred tax benefit as a result of the enactment of the cantonal law in the fourth quarter; however we are currently unable to reasonably estimate such amount as the Swiss authorities are still providing interpretive guidance on the new law and related transitional methodology.

Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 18 to our consolidated financial statements for the year ended December 31, 2018.

U.S. Operations (amounts in thousands)

Three months ended September 30, Nine months ended September 30,
2019 2018% 2019 2018%
Total net sales $297,113 $280,429 6% $852,369 $808,801 5%
Net sales to external customers $269,038 $255,379 5% $771,578 $736,598 5%
Segment profit $54,628 $41,890 30% $146,599 $118,141 24%

Total net sales and net sales to external customers increased 6% and 5% for the three months ended September 30, 2019 compared with the corresponding period in 2018. Total net sales and net sales to external customers both increased 5% for the nine months ended September 30, 2019 compared with the corresponding period in 2018. The increase in total net sales and net sales to external customers includes particularly strong growth in laboratory-related products, partially offset by a significant decline in food retailing primarily due to unfavorable market conditions and the timing of project activity which reduced total net sales and net sales to external customers by 3% and 2% for the three and nine months ended September 30, 2019, respectively. The increase during the three month period also included strong growth in core industrial products.

Segment profit increased $12.7 million and $28.5 million for the three and nine months ended September 30, 2019, respectively, compared to the corresponding periods in 2018. The segment profit increase includes higher net sales volume and benefits from our margin expansion and facility consolidation initiatives, offset in part by investments in our sales and service organization and initial costs of new product introductions.

Swiss Operations (amounts in thousands)

Three months ended September 30, 2019 2018 %1) Nine months ended September 30, 2019 2018 %1)
Total net sales $194,151 $179,881 8% $564,748 $537,041 5%
Net sales to external customers $33,415 $31,463 6% $98,350 $96,082 2%
Segment profit $54,226 $44,542 22% $156,361 $138,254 13%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales increased 8% in both U.S. dollars and local currency for the three months ended September 30, 2019, and increased 5% in U.S. dollars and 8% in local currency for the nine months ended September 30, 2019 compared to the corresponding periods in 2018. Net sales to external customers increased 6% in both U.S. dollars and local currency for the three months ended September 30, 2019 and increased 2% in U.S. dollars and 4% in local currency for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Local currency net sales to external customers for the three and nine months ended September 30, 2019 includes strong growth in industrial-related products.

Segment profit increased $9.7 million and $18.1 million for the three and nine month periods ended September 30, 2019, compared to the corresponding periods in 2018. Segment profit during the nine months ended September 30, 2019 includes benefits from our increased net sales volume and margin expansion and cost savings initiatives, offset in part by unfavorable foreign currency translation and higher research and development activity.

Western European Operations (amounts in thousands)

Three months ended September 30, 2019 2018 %1) Nine months ended September 30, 2019 2018 %1)
Total net sales $211,446 $215,093 (2)% $624,290 $640,390 (3)%
Net sales to external customers $168,652 $173,170 (3)% $498,240 $512,314 (3)%
Segment profit $29,888 $30,046 (1)% $77,842 $75,661 3%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales decreased 2% in U.S. dollars and increased 3% in local currencies for the three months ended September 30, 2019 and decreased 3% in U.S. dollars and increased 4% in local currencies for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Net sales to external customers decreased 3% in U.S. dollars and increased 2% in local currencies for the three months ended September 30, 2019, and decreased 3% in U.S. dollars and increased 4% in local currencies for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Local currency net sales to external customers for the three and nine months ended September 30, 2019 includes strong growth in core industrial products, pipettes and process analytics, offset in part by a decline in food retailing. The decline in food retailing reduced net sales by 2% and 1% for the three and nine months ended September 30, 2019, respectively.

Segment profit decreased $0.2 million and increased $2.2 million for the three and nine month periods ended September 30, 2019, respectively, compared to the corresponding periods in 2018. Segment profit for the three and nine months ended September 30, 2019 includes increased research and development and sales and marketing investments, initial costs associated with new product introductions and unfavorable currency translation, offset in part by higher net sales and benefits from our margin expansion initiatives. Segment profit for the nine months ended September 30, 2018 also included Blue Ocean roll-in costs.

Chinese Operations (amounts in thousands)

Three months ended September 30, 2019 2018 %1) Nine months ended September 30, 2019 2018 %1)
Total net sales $203,002 $204,177 (1)% $570,608 $570,375 0%
Net sales to external customers $142,292 $140,098 2% $400,473 $387,301 3%
Segment profit $72,745 $75,762 (4)% $197,718 $201,199 (2)%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 1% in U.S. dollars and increased 2% in local currency for the three months ended September 30, 2019 and were flat in U.S. dollars and increased 5% in local currency for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Net sales to external customers increased 2% in U.S. dollars and 5% in local currency for the three months ended September 30, 2019 and increased 3% in U.S. dollars and 9% in local currency during the nine months ended September 30, 2019, compared to the corresponding periods in 2018. The increase in local currency net sales to external customers during the three and nine months ended September 30, 2019 reflects solid growth in laboratory and core industrial products. Total net sales for the three months ended September 30, 2019 is partially offset by a decline in food retailing. While Chinese market conditions are currently favorable, the Chinese economy has historically been volatile and market conditions may change unfavorably due to various factors.

Segment profit decreased $3.0 million and $3.5 million for the three and nine month periods ended September 30, 2019, respectively, compared to the corresponding periods in 2018. The decrease in segment profit for the three and nine months ended September 30, 2019 includes unfavorable foreign currency translation, increased sales and service investments, and higher research and development activity, offset in part by increased sales volume and benefits from our margin expansion initiatives.

Other (amounts in thousands)

Three months ended September 30, 2019 2018 %1) Nine months ended September 30, 2019 2018 %1)
Total net sales $141,982 $136,070 4% $400,151 $389,804 3%
Net sales to external customers $140,469 $134,736 4% $396,043 $385,368 3%
Segment profit $17,938 $19,179 (6)% $45,425 $50,702 (10)%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales and net sales to external customers increased 4% in U.S. dollars and 5% in local currencies for the three months ended September 30, 2019 and increased 3% in U.S. dollars and 5% in local currencies for the nine months ended September 30, 2019, compared to the corresponding periods in 2018. Local currency growth in net sales to external customers included solid growth in most product categories.

Segment profit decreased $1.2 million and $5.3 million for the three and nine months ended September 30, 2019, respectively, compared to the corresponding periods in 2018. The decrease in segment profit is primarily related to investments in field sales and service and unfavorable currency translation, offset in part by increased local currency net sales.

Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $401.7 million during the nine months ended September 30, 2019, compared to $366.4 million in the corresponding period in 2018. The increase in 2019 includes higher net earnings and lower cash incentive payments of $18 million, offset in part by the timing of working capital outflows.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $71.6 million for the nine months ended September 30, 2019 compared to $96.7 million in the corresponding period in 2018. The decrease is primarily related to prior year investments in manufacturing facilities. We expect to make net investments in new or expanded manufacturing facilities of $10 million to $15 million over the next two years.

We recorded charges of $3.6 million and $72 million in 2018 and 2017, respectively, for the estimated income tax effects of the Transition Tax associated with the Tax Cuts and Jobs Act of which $62 million is expected to be paid over a period of up to eight years. We also plan to continue to repatriate earnings from China, Switzerland, Germany, the United Kingdom, and certain other countries in future years and expect the only additional cost associated with the repatriation of such foreign earnings will be withholding taxes. All other undistributed earnings are considered to be permanently reinvested. We believe the ongoing tax impact associated with repatriating our undistributed foreign earnings will not have a material effect on our liquidity.

Senior Notes and Credit Facility Agreement

Our debt consisted of the following at September 30, 2019:

September 30, 2019 U.S. Dollar Other Principal Trading Currencies Total
3.67% $50 million Senior Notes due December 17, 2022 50,000 — 50,000
4.10% $50 million Senior Notes due September 19, 2023 50,000 — 50,000
3.84% $125 million Senior Notes due September 19, 2024 125,000 — 125,000
4.24% $125 million Senior Notes due June 25, 2025 125,000 — 125,000
3.91% $75 million Senior Notes due June 25 2029 75,000 — 75,000
1.47% EUR 125 million Senior Notes due June 17, 2030 — 136,747 136,747
Debt issuance costs, net (1,111) (307) (1,418)
Total Senior Notes 423,889 136,440 560,329
$1.1 billion Credit Agreement, interest at LIBOR plus 87.5 basis points 485,016 78,934 563,950
Other local arrangements 1,058 47,519 48,577
Total debt 909,963 262,893 1,172,856
Less: current portion (1,058) (47,519) (48,577)
Total long-term debt $908,905 $215,374 $1,124,279

As of September 30, 2019, approximately $529.2 million was available under the Credit Agreement. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.

We currently believe that cash flow from operating activities, together with liquidity available under our credit facility and local working capital facilities, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for at least the foreseeable future.

1.30% Euro-Senior Notes and 3.19% Senior Notes

In November 2019, we entered into an agreement to issue and sell EUR 135 million of fifteen-year 1.30% Euro-Senior Notes ("1.30% Senior Notes") and $50 million of fifteen-year 3.19% Senior Notes ("3.19% Senior Notes") in a private placement. The proceeds will be used to repay outstanding amounts on our credit facility and fund operational expenses. We also entered into a forward contract to receive $149.9 million at the time of issuing the EUR 135 million Euro-Senior Notes.

We issued the 1.30% Euro-Senior Notes with a fixed interest rate of 1.30% in November 2019. The 1.30% Euro-Senior Notes are unsecured obligations of the Company and will mature in November 2034. Interest on the 1.30% Euro-Senior Notes is payable semi-annually in April and November of each year.

We will issue the 3.19% Senior Notes with a fixed interest rate of 3.19% in January 2020. The 3.19% Senior Notes are unsecured obligations of the Company and will mature in January 2035. Interest on the 3.19% Senior Notes is payable semi-annually in January and July of each year.

We will designate the 1.30% Euro-Senior Notes as a hedge of a portion of its net investment in euro-denominated foreign subsidiaries to reduce foreign currency risk associated with the net investment in these operations. Changes in the fair value of this debt resulting from fluctuations in the euro to U.S. dollar exchange rates will be recorded as foreign currency translation adjustments within other comprehensive income (loss). We may at any time prepay the Senior Notes, in whole or in part, at a price equal to 100% of the principal amount thereof plus accrued and unpaid interest, and if applicable a "make-whole" prepayment premium and a swap related currency loss.

3.91% Senior Notes

In April 2019, the Company entered into an agreement to issue and sell $75 million of ten-year Senior Notes in a private placement. The Company issued the Senior Notes with a fixed interest rate of 3.91% ("3.91% Senior Notes") in June 2019. The 3.91% Senior Notes are unsecured obligations of the Company and will mature in June 2029. Interest on the 3.91% Senior Notes is payable semi-annually in June and December of each year. The proceeds were used to repay outstanding amounts on the Company's credit facility.

The 3.91% Senior Notes, the 1.30% Euro-Senior Notes and the 3.19% Senior Notes contain customary affirmative and negative covenants for agreements of this type that are substantially similar to those contained in previously issued debt of the Company. The 3.91% Senior Notes, 1.30% Euro-Senior Notes and the 3.19% Senior Notes also contain customary events of default with customer grace periods, as applicable.

Other Local Arrangements

In April 2018, two of our non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of Swiss franc LIBOR plus 87.5 basis points. The loans were renewed for one year in April 2019 and, as such are classified as short-term debt on our consolidated balance sheet.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness.

Share Repurchase Program

We have a share repurchase program of which there was $1.5 billion of remaining common shares to be repurchased under the program as of September 30, 2019. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and existing cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors.

We have purchased 28.3 million shares since the inception of the program through September 30, 2019. During the nine months ended September 30, 2019 and 2018, we spent $558.7 million and $356.2 million on the repurchase of 794,603 and 598,539 shares at an average price per share of $703.16 and $595.18, respectively. We also reissued 226,841 shares and 102,174 shares held in treasury for the exercise of stock options and restricted stock units during the nine months ended September 30, 2019 and 2018, respectively.

Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.6 million to $1.8 million annually.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $1.3 million to $1.5 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at September 30, 2019, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $29.2 million in the reported U.S. dollar value of our debt.

Forward-Looking Statements Disclaimer

You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue”.

We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position , capital expenditures, cash flow, tax-related matters, compliance with laws, and effects of acquisitions.

Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2018 Annual Report on Form 10-K.

Market risk

As filed, 178 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of September 30, 2019, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Controls and procedures

As filed, 708 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 204 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For the nine months ended September 30, 2019 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$753.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-01-01 to 2019-09-30$2.16bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit3 months2019-07-01 to 2019-09-30$435.1mus-gaap:GrossProfit
Gross profit9 months2019-01-01 to 2019-09-30$1.24bnus-gaap:GrossProfit
Research and development3 months2019-07-01 to 2019-09-30$36.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-01-01 to 2019-09-30$108.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-07-01 to 2019-09-30$202.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2019-01-01 to 2019-09-30$612.5mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2019-07-01 to 2019-09-30$9.8mus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-30$27.8mus-gaap:InterestExpense
Income tax3 months2019-07-01 to 2019-09-30$40.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-01-01 to 2019-09-30$81.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-30$129.4mus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30$368.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30$5.20us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-01-01 to 2019-09-30$14.67us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-07-01 to 2019-09-30$5.28us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-01-01 to 2019-09-30$14.93us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-07-01 to 2019-09-3024,880,179 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-01-01 to 2019-09-3025,103,173 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-01-01 to 2019-09-30$401.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-01-01 to 2019-09-30$71.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2019-01-01 to 2019-09-30$558.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-09-30$120.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$963.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$2.64bnus-gaap:Assets
Current liabilitiesAt period end2019-09-30$719.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$2.20bnus-gaap:Liabilities
Long-term debtAt period end2019-09-30$1.12bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-09-30$48.6mus-gaap:DebtCurrent
Shareholders' equityAt period end2019-09-30$438.3mus-gaap:StockholdersEquity
Shares outstandingAt period end2019-09-3024,354,201 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001037646-19-000040. Last ingested by Listed: Nov 13, 2026, 02:43 ET. Listed shows no prices and gives no investment advice.